Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Luminex Corporation Aries SARS-CoV-2 Assay

ASPR’s Portfolio of COVID-19 Medical Countermeasures under EUA

BARDA has partnered with is supporting Luminex Corporation to develop a sample-to-answer SARS-CoV-2 assay on its IVD ARIES® molecular diagnostic system that can be run in moderate complexity labs.  This technology will extend testing capability to many more labs and patients by enabling community hospitals without access to expensive equipment to run molecular SARS-CoV-2 assays. To learn more, see the award announcement.

Emergency Use Authorization

On April 3, 2020, FDA issued an Emergency Use Authorization (EUA) to allow Luminex Corporation’s NxTAG CoV Extended Panel to be used to diagnose COVID-19.


  • This page last reviewed: May 21, 2020